Group One Trading
MLYS icon

Group One Trading’s Mineralys Therapeutics MLYS Stock Holding History

Group One Trading’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.3M Buy
122,300
+49,200
+67% +$1.35M ﹤0.01% 1761
2026
Q1 		$1.98M Sell
73,100
-73,900
-50% -$2.17M ﹤0.01% 2078
2025
Q4 		$5.33M Buy
147,000
+128,100
+678% +$5.14M 0.01% 1427
2025
Q3 		$717K Buy
18,900
+17,600
+1,354% +$381K ﹤0.01% 3336
2025
Q2 		$17.6K Sell
1,300
-2,500
-66% -$36.2K ﹤0.01% 6344
2025
Q1 		$60.3K Buy
+3,800
New +$43.7K ﹤0.01% 5010

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Group One Trading's MLYS Position: Q2 2026 in Review

Group One Trading opened a new position in Mineralys Therapeutics (MLYS) in Q2 2026: 25,471 shares worth $687K. The stake represents ﹤0.01% of the portfolio and ranks #3209 among its holdings. This is a return to the name: Group One Trading previously reported a position in MLYS as recently as Q2 2025.

Group One Trading first reported a position in MLYS in Q1 2025 and has held it in 3 quarters since. 225 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Group One Trading held 25,471 shares of Mineralys Therapeutics worth $687K as of Q2 2026.
  • Mineralys Therapeutics was a new Group One Trading position in Q2 2026.
  • Mineralys Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3209 holding.
  • Group One Trading first reported a position in Mineralys Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 225 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.